Preamble
The Ontario Public Health Standards (OPHS) are published by the Minister of Health and LongTerm Care under the authority of the Health Protection and Promotion Act (HPPA) 1 to specify the mandatory health programs and services provided by boards of health. Protocols are program and topic specific documents which provide direction on how boards of health must operationalize specific requirement(s) identified within the OPHS. They are an important mechanism by which greater standardization is achieved in the province-wide implementation of public health programs.
Protocols identify the minimum expectations for public health programs and services. Boards of health have the authority to develop programs and services in excess of minimum requirements where required to address local needs. Boards of health are accountable for implementing the standards including those protocols that are incorporated into the standards.
Purpose
The purpose of this protocol is to provide direction to boards of health to reduce the burden of tuberculosis (TB) through prevention and control. Confirmed and suspect cases c) Create the person as a suspect or confirmed case in iPHIS or any other method specified by the ministry within 24 hours of receiving the initial report.
More detailed information on implementation can be obtained in the most current version of the Tuberculosis Prevention and Control Best Practices document (currently called TB Protocol, 2006).
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Reference to the Standards
Additional information on cases d) Enter into iPHIS or any other method specified by the ministry all initial laboratory, sensitivity, and radiological reports within 24 hours of receipt.
e) Enter into iPHIS or any other method specified by the ministry any additional data elements as specified in O. Reg. 569 (Reports), 3 as soon as possible, but in any event not later than 30 calendar days of receipt.
Information for TB contacts f) Enter into iPHIS or any other method specified by the ministry demographics, episode status, and the link to the source case within 30 calendar days of identification of the contact.
g) Enter into iPHIS or any other method specified by the ministry any additional data elements as soon as possible, but in any event not later than 30 calendar days of receipt.
Immigration medical surveillance h) Enter into iPHIS or any other method specified by the ministry demographics and episode status of persons self-reporting for immigration medical surveillance within 30 calendar days of the person reporting.
i) Enter into iPHIS or any other method specified by the ministry additional data elements for persons on medical surveillance as soon as possible, but in any event not later than 30 calendar days of receipt.
Latent TB infection (LTBI) j) Enter all required data elements in accordance with the current iPHIS Tuberculosis (TB)
User Guide 4 into iPHIS or any other method specified by the ministry as soon as possible, but in any event not later than 30 calendar days of receipt.
2) Surveillance
The board of health shall on an annual basis: 
3) Early identification of TB cases, including referrals of persons with inactive TB through immigration medical surveillance
The board of health shall: iv) Facilitate medical assessment for active TB disease and/or LTBI, including sputum collection if the individual has signs or symptoms of active TB, tuberculin skin testing (TST) as appropriate and chest X-ray. This should be completed within three months of the person obtaining OHIP coverage, or earlier if required; and v) Utilize strategies to facilitate the early identification of active TB in individuals referred for medical surveillance (e.g., follow for two years those persons with LTBI who do not complete prophylaxis and/or educate them about the signs and symptoms of TB disease, and the need to seek medical attention should these develop).
4) Management of TB cases
The board of health shall: e) Recommend that a TB specialist provides treatment for or is consulted on all cases resistant to two or more drugs, as well as all cases determined to be treatment failures.
f) Have a mechanism in place to provide directly observed therapy (DOT) ‡ for: i) All respiratory TB cases for a minimum of eight weeks or while the person is infectious, whichever is longer; ii) All cases (respiratory or nonrespiratory TB) resistant to two or more first line drugs for the duration of treatment; iii) All cases (respiratory or nonrespiratory TB) with treatment failure or reactivated TB for the duration of treatment; and iv) All cases (respiratory or nonrespiratory TB) while they are being treated on an intermittent therapy regimen.
g) Utilize a DOT assessment tool and clinical judgment to identify TB cases that are likely to be non-compliant and may require DOT for the duration of therapy.
h) Contact persons with respiratory TB, who are no longer on DOT, at a minimum of once every month to monitor the treatment response, compliance and drug toxicity until the completion of therapy. The frequency of monitoring all nonrespiratory cases shall be based on clinical judgment. i) Ensure that respiratory isolation is discontinued only when a case is considered to be no longer infectious. j) Have a mechanism in place to ensure the provision of publicly funded TB medications at no cost to the person with TB or the provider. k) Review drug regimens and sensitivity results to ensure appropriateness and adequacy of therapy.
l) Monitor patient compliance with prescribed drug regimens, including completion and outcome of therapy. ‡ DOT means that the person is observed taking their TB medication by a trained observer on all business days that treatment is required. c) Recommend and facilitate prophylaxis for the following high priority contacts who do not have active TB disease even if they are assessed as being tuberculin skin test (TST) negative: i) children under age 5 years -prophylaxis should be continued for at least eight weeks from break in contact and reassessment should be carried out before prophylaxis is discontinued; and ii) contacts with HIV infection or other severe immunodeficiency should receive a full course treatment of LTBI regardless of the TST results.
d) Direct close contacts who are not high priority to complete contact follow-up evaluation within four months from break in contact or one month of identification, whichever is later.
e) Identify any additional contacts (beyond those considered to be close contacts) within one month of notification of the source case. Direct the additional contacts for whom followup is considered appropriate, to complete follow-up within four months from break in contact or one month of identification, whichever is later.
f) Facilitate follow-up of all contacts who are symptomatic for TB disease or (TST) positive to rule out active disease and for consideration of prophylaxis.
6) Identification and management of individuals with LTBI
The board of health shall: a) Implement strategies to promote the identification and treatment of persons with LTBI. This shall include annual education of health care providers and/or community stakeholders about: i) Considering LTBI in those with risk factors; ii) Reporting persons with LTBI according to the HPPA 1 ; iii) Screening of high-risk groups; and iv) The need to offer treatment for those with LTBI as appropriate and ensure treatment completion.
b) Have a mechanism in place to ensure the provision of publicly funded TB medications for persons on LTBI therapy at no cost to the person with LTBI or the provider.
Glossary
Contact: a person identified as having come in contact with a case of infectious active TB disease. Contacts may be classified as high priority, close household, close non-household or casual or community contacts.
Close household contacts: those individuals who live in the same household as the infectious case of TB. Household contacts are considered by definition to share breathing space on a daily basis with the source case. Under certain circumstances, those who share prison cells, shelters, university dormitories and army barracks may also be considered close household contacts.
Close non-household contacts: those individuals who have regular, prolonged contact with the index case and share breathing space daily, but do not live in the same household. These include sexual partners, those with frequent/regular direct face-to-face exposure at work, and regular social contacts.
Casual contacts: those who spend time less frequently with the infectious case or have had less direct exposure. These individuals may include classmates, colleagues at work, or members of a club or team.
Community contacts: those living in the same community or attending the same school or workplace.
High priority contacts: include close household contacts, children under age five years, those with risk factors for progression of LTBI to TB disease, and contacts exposed during bronchoscopy, sputum induction, autopsy and other high-risk medical procedures. i) Non-calcified pleural fibrosis and/or effusion likely related to TB ii) Parenchymal lung disease likely related to TB iii) Acute pulmonary disease likely related to TB e) A chest X-ray graded 4.7 (any cavitating lesion or "fluffy" or "soft" lesions likely related to TB) or with extensive, significant anomalies that render the determination of radiological stability difficult and/or doubtful.
Urgent Immigration Medical
f) A known case of treated MDR-TB or XDR-TB.
g) Any individual who is understood to have received treatment for two or more independent episodes of TB in the past (respiratory or nonrespiratory).
h) Any individual with a past history of TB that received particularly unusual/unconventional treatment, as determined by a CIC Medical Officer after consultation with a Canadian TB specialist.
